The weight loss drug category is rapidly evolving, with J.P. Morgan Research predicting up to 30 million Americans could be on these medications by 2030 and $100 billion in revenues by the same time. Obesity expert Dr. Angela Fitch states that obesity is a “number-one disease” in the US, making the market opportunity even larger.
As new drugs enter the market, experts predict that they will have a significant impact on various categories such as food, wellness, beauty, and retail. Companies like Hims & Hers, Wisp, Found, PlushCare, and others are offering online programs to make prescription processes more seamless. Manufacturers have also increased supply to meet growing demand.
New formulations, such as pills, are in development, which could shake up the market by offering an alternative to weekly injections. New hormones are being added to these drugs, making them more sophisticated. Experts predict that these drugs will not only be used for weight loss but also for a range of conditions associated with obesity and beyond.
However, experts warn that there will be challenges in the category, particularly with insurance coverage and conversations surrounding the drugs. Changes in insurance coverage could lead to reduced coverage of these medications across the board, resulting in financial issues for patients and increased frustration.
Source: https://wwd.com/beauty-industry-news/wellness/ozempic-2025-predictions-1236770212